Composition with antioxidant, moisturizing and lubricating effects and application thereof
A technology of lubricating effect and composition, applied in the field of medical devices, can solve the problems of ineffective removal of free radicals in the eye, eye irritation, insufficient lubricating and moisturizing effect, etc., so as to relieve eye fatigue and discomfort, improve wearing comfort, protect eye effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] (1) Weigh ectoine 1%, collagen 0.1%, ergothioneine 0.02%, humectant sodium hyaluronate 0.1%, surfactant poloxamer-407 0.1%, chelating agent EDTA-2Na 0.05 %, borate buffer 0.01-10%, osmotic pressure regulator NaCl 0.01-2% and water for injection;
[0040] (2) dissolve the borate buffer weighed in step (1) in water for injection to obtain solution A, and adjust the pH to 6.5-7.5;
[0041] (3) the sodium hyaluronate, poloxamer-407, EDTA-2Na and 80% solution A that were weighed in step (1) were continuously stirred at 60°C until completely dissolved to prepare solution B, which was cooled to room temperature;
[0042](4) ectoine, collagen and ergothioneine taken by step (1) are dissolved in remaining solution A to complete dissolution to obtain solution C;
[0043] (5) Mix solution B and solution C evenly, add the NaCl weighed in step (1) to adjust the osmotic pressure to 300mOsm / (Kg·H 2 0), carry out filtration sterilization, subpackage, and get final product.
Embodiment 2
[0045] (1) Weigh ectoine 2%, collagen 0.01%, ergothioneine 0.05%, sodium hyaluronate 0.1%, poloxamer-407 0.1%, EDTA-2Na 0.05%, borate buffer 0.01~10%, NaCl 0.01~2% and water for injection;
[0046] (2) dissolve the borate buffer weighed in step (1) in water for injection to obtain solution A, and adjust the pH to 6.5-7.5;
[0047] (3) the sodium hyaluronate, poloxamer-407, EDTA-2Na and 80% solution A that were weighed in step (1) were continuously stirred at 60 ° C until completely dissolved to prepare solution B, which was cooled to room temperature;
[0048] (4) Dissolving the ectoine, collagen and ergothioneine weighed in step (1) in the remaining solution A to complete dissolution to obtain solution C.
[0049] (5) Mix solution B and solution C evenly, add the NaCl weighed in step (1) to adjust the osmotic pressure to 300mOsm / (Kg·H 2 0), carry out filtration sterilization, subpackage, and get final product.
Embodiment 3
[0051] (1) Weigh ectoine 0.5%, collagen 0.3%, ergothioneine 0.2%, sodium hyaluronate 0.1%, poloxamer-407 0.1%, EDTA-2Na 0.05%, borate buffer 0.01-10%, NaCl 0.01-2% and water for injection. ;
[0052] (2) dissolve the borate buffer weighed in step (1) in water for injection to obtain solution A, and adjust the pH to 6.5-7.5;
[0053] (3) the sodium hyaluronate, poloxamer-407, EDTA-2Na and 80% solution A that were weighed in step (1) were continuously stirred at 60 ° C until completely dissolved to prepare solution B, which was cooled to room temperature;
[0054] (4) Dissolving the ectoine, collagen and ergothioneine weighed in step (1) in the remaining solution A to complete dissolution to obtain solution C.
[0055] (5) Mix solution B and solution C evenly, add the NaCl weighed in step (1) to adjust the osmotic pressure to 300mOsm / (Kg·H 2 0), carry out filtration sterilization, subpackage, and get final product.
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com